Using a multisensory room to help children with autism
Effects of Integrated Therapy Using the Multisensory Room in Autism Spectrum Disorder
This study is testing if a special room filled with different sensory experiences can help young children with autism feel better and behave better compared to those getting regular treatment.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 3 Years to 6 Years |
| Sex | All |
| Sponsor | IRCCS Centro Neurolesi Bonino Pulejo Academic / other |
| Locations | 1 site (Messina) |
| Trial ID | NCT06184802 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the feasibility and effectiveness of an integrated treatment program that utilizes a multisensory room for children diagnosed with Autism Spectrum Disorder (ASD). The multisensory environment is designed to provide various sensory stimulation opportunities, addressing the atypical sensory processing often seen in ASD. Participants aged 3 to 6 years will be compared against a control group receiving usual treatment to assess any improvements in behavior and sensory integration. The study will involve family participation to enhance the therapeutic process.
Who should consider this trial
Good fit: Ideal candidates for this study are children aged 3 to 6 years who have been diagnosed with Autism Spectrum Disorder.
Not a fit: Children outside the age range of 3 to 6 years or those with significant medical conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to improved sensory processing and reduced challenging behaviors in children with autism.
How similar studies have performed: Previous studies have shown potential benefits of multisensory environments for children with ASD, suggesting this approach may be promising.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients diagnosed with diagnosis of ASD, according to Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria; * age between 3 and 6 years; * signed informed consent and the availability of at least one family member to participate in the diagnostic/therapeutic process. Exclusion Criteria: * children not aged between 3 and 6 years; * significant medical conditions such as epilepsy, significant visual and auditory sensory deficits, traumatic brain injury, or significant genetic disorders. * Informed consent not signed of at least one family member to participate in the diagnostic/therapeutic process.
Where this trial is running
Messina
- IRCCS Neurolesi Bonino Pulejo — Messina, Italy (Recruiting)
Study contacts
- Study coordinator: Francesca Cucinotta, MD, PhD
- Email: francesca.cucinotta@irccsme.it
- Phone: 09060128256
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.